Predictors of continued HIV-risk behaviors among drug users in methadone maintenance therapy program in China-A prospective study

Harm Reduction Journal

Volumn 10, Issue 1, 2013, Pages

  Chen, Wen ^a   Xia, Yinghua ^a   Hong, Yan ^b   Hall, Brian J ^a,c,d   Ling, Li ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNC Project China   (China)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

China; HIV risk behaviors; Longitudinal study; Methadone maintenance therapy

Indexed keywords

METHADONE; NARCOTIC AGENT;

ADULT; ARTICLE; CHINA; DRUG DEPENDENCE; DRUG USE; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PATIENT COMPLIANCE; PROSPECTIVE STUDY; SEXUAL BEHAVIOR; SEXUALITY; STRUCTURED INTERVIEW; SYRINGE; HEPATITIS C; HIGH RISK BEHAVIOR; MEDICATION COMPLIANCE; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PSYCHOLOGICAL ASPECT; STATISTICS; SUBSTANCE ABUSE; UNSAFE SEX;

ADULT; CHINA; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDIES; RISK-TAKING; SEXUAL PARTNERS; SUBSTANCE ABUSE, INTRAVENOUS; UNSAFE SEX;

EID: 84885107432     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-10-23     Document Type: Article

References (57)

1. United Nations Office on Drugs and Crime World drug report 2012 2012, Vienna: United Nations publication, Sales No. E.12.XI.1, United Nations Office on Drugs and Crime.
2. Dole VP, Nyswander M. Methadone maintenance 4 decades later thousands of lives saved but still controversial. JAMA 2008, 300(19):2303-2305. 10.1001/jama.2008.648, 19017918.
3. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009, 3. CD002209.
4. Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM. Methadone maintenance vs 180-Day psychosocially enriched detoxification for treatment of opioid dependence a randomized controlled trial. JAMA 2000, 283(10):1303-1310. 10.1001/jama.283.10.1303, 10714729.
5. Metzger DS, Woody GE, O'Brien CP. Drug treatment as HIV prevention: a research update. J Acquir Immune Defic Syndr 2010, 55(Suppl 1):32-36.
6. Sorensen JL, Coepland AL. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend 2000, 59(1):17-31. 10.1016/S0376-8716(99)00104-0, 10706972.
7. Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988, 29(2):214-226.
8. Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep 1998, 113(Suppl 1):107-115.
9. Choopanya K, Des Jarlais DC, Vanichseni S, Mock PA, Kitayaporn D, Sangkhum U, Prasithiphol B, Hiranrus K, van Griensven F, Tappero JW, et al. HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr 2003, 33(1):88-95. 10.1097/00126334-200305010-00013, 12792360.
10. Qian HZ, Hao C, Ruan Y, Cassell HM, Chen K, Qin G, Yin L, Schumacher JE, Liang S, Shao Y. Impact of methadone on drug use and risky sex in China. J Subst Abuse Treat 2008, 34(4):391-397. 10.1016/j.jsat.2007.07.002, 17869049.
11. Department of Health and Human Services Methadone maintenance treatment 2002, Atlanta: Centers for Disease Control and Prevention, Department of Health and Human Services.
12. National Narcotic Control Commission Annual National Narcotic Control Report 2011 2011, Beijing: Ministry of Public Security, National Narcotic Control Commission.
13. Qian HZ, Schumacher JE, Chen HT, Ruan YH. Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications. Harm Reduction J 2006, 3:4.
14. Standing Office of National People's Congress China Standing Office of National People's Congress China. Regulations on Prohibition against Narcotics 1990, Beijing: Standing Office of National People's Congress, Standing Office of National People's Congress China.
15. Wang L. Overview of the HIV/AIDS epidemic, scientific research and government responses in China. AIDS 2007, 21(Suppl 8):3-7.
16. Ministry of Health China, UNAIDS, WHO The estimation of HIV/AIDS epidemic in China, 2011 2011, Beijing: National center for AIDS/STD control and prevention, China CDC, Ministry of Health China, UNAIDS, WHO.
17. Yin W, Hao Y, Sun X, Gong X, Li F, Li J, Rou K, Sullivan SG, Wang C, Cao X, et al. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol 2010, 39(Suppl 2):29-37.
18. Li J, Ha TH, Zhang C, Liu H. The Chinese government's response to drug use and HIV/AIDS: A review of policies and programs. Harm Reduction J 2010, 5(7):4.
19. Ministry of Health China, Ministry of Security China, State FDA China National guideline of community-based methadone maintenance treatment to opioid-addicts in China 2006, Bei Jing: Ministry of Health China, Ministry of Health China, Ministry of Security China, State FDA China.
20. He Q, Wang XR, Xia YH, Mandel JS, Chen A, Zhao LL, Han L, Ling L. New community-based methadone maintenance treatment programs in Guangdong, China, and their impact on patient quality of life. Subst Use Misuse 2011, 46(6):749-757. 10.3109/10826084.2010.534124, 21114401.
21. Gu J, Xu HF, Lau JTF, Hao YT, Zhong Y, Fan LR, Zhao YT, Hao C, Ling WH. Misconceptions predict prospectively dropout and poor adherence among newly admitted first-time methadone maintenance treatment clients in Guangzhou, China. Addiction 2012, 107(9):1641-1649. 10.1111/j.1360-0443.2012.03859.x, 22360534.
22. Chen A, Xia YH, Chen W, Ling L, Tan WK, Zheng JR. Predictors of retention related factors at the initial methadone maintenance treatment clinics in Guangdong province. Zhonghua Liu Xing Bing Xue Za Zhi 2009, 30(12):1230-1233.
23. Li XL, Tan HZ, Sun ZQ, Zhang H, Chen MS, Ou QY. Study on the time of retention and related influencing factors of patients receiving methadone maintenance treatment in Hunan province. Zhonghua Liu Xing Bing Xue Za Zhi 2009, 30(7):672-675.
24. Wang ZC, Zhong HJ, Wang L, Huang GY, Li SC, Li JL. Factors and interventions associated with adherence to methadone maintenance treatment. China Prev Med 2008, 9(4):309-312.
25. Zhang YZ, Shan H, Trizzino J, Ruan YH, Beauchamp G, Mâsse B, Jun M, Yuan G, Yixin H, Baoling R, et al. Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China. J Infect 2007, 54(3):285-290. 10.1016/j.jinf.2006.06.001, 16831464.
26. Ruan YH, Qin GM, Liu SZ, Qian HZ, Zhang L, Zhou F, He Y, Chen K, Yin L, Chen X, et al. HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan province, China. J Acquir Immune Defic Syndr 2005, 39(4):459-463. 10.1097/01.qai.0000152398.47025.0f, 16010170.
27. Lee TS, Shen HC, Wu WH, Huang CW, Yen MY, Wang BE, Chuang P, Shih CY, Chou YC, Liu YL. Clinical characteristics and risk behavior as a function of HIV status among heroin users enrolled in methadone treatment in northern Taiwan. Subst Abuse Treat Prev Policy 2011, 8(6):6.
28. Avants SK, Warburton LA, Hawkins KA, Margolin A. Continuation of high -risk behavior by HIV-positive drug users treatment implication. J Subst Abuse Treat 2000, 19(1):15-22. 10.1016/S0740-5472(99)00092-6, 10867296.
29. Corsi KF, Lehman WK, Booth RE. The effect of methadone maintenance on positive outcomes for opiate injection drug users. J Subst Abuse Treat 2009, 37(2):120-126. 10.1016/j.jsat.2008.11.004, 2741097, 19150202.
30. Li H, Goggins W, Lee SS. Multilevel analysis of HIV related risk behaviors among heroin users in a low prevalence community. BMC Public Health 2009, 12(9):137.
31. He X. The number of HIV infected individuals in Guangdong Province has been reduced 16000 within the last 16 years. Guangzhou Daily 2012, 11-29. Guangzhou: Guangzhou Daily Press.
32. Li NN. Sixty and thirty percentages of new HIV infections in Guangdong last year because of sexually and drug injected transmisiion, respectively 2011, Guangzhou: Information times.
33. Department of Health of Guangdong Province Report on HIV/AIDS prevention and control of Guangdong province, 2011 2011, Guangzhou: Department of Health, Department of Health of Guangdong Province.
34. World Health Organization International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) Version for 2010 http://apps.who.int/classifications/icd10/browse/2010/en, World Health Organization.
35. Liu EW, Liang T, Shen LM, Zhong H, Wang B, Wu ZY, Detels R. Impact of methadone maintenance treatment on HIV risk behaviors of heroin drug users. Zhonghua Yu Fang Yi Xue Za Zhi 2010, 44(11):981-984.
36. Zhao L, Holzemer WL, Johnson M, Tulsky JP, Rose CD. HIV infection as a predictor of methadone maintenance outcomes in Chinese injection drug users. AIDS Care 2012, 24(2):195-203.
37. Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry 2006, 63(2):201-208. 10.1001/archpsyc.63.2.201, 16461864.
38. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974, 19(6):716-723.
39. Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, Shore R, Hopkins S. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program. AIDS Educ Prev 2007, 19(2):124-136. 10.1521/aeap.2007.19.2.124, 17411415.
40. Strathdee SA, Patterson TL. Behavioral interventions for HIV-positive and HCV-positive drug users. AIDS Behav 2006, 10(2):115-130. 10.1007/s10461-005-9055-5, 16463006.
41. Murphy DA, Brecht ML, Herbeck D, Evans E, Huang D, Hser YI. Longitudinal HIV risk behavior among the Drug Abuse Treatment Outcome Studies (DATOS) adult sample. Eval Rev 2008, 32(1):83-112. 10.1177/0193841X07307411, 2538490, 18198171.
42. Guo YL, Zhou JB, Hao C, Shi TP, Li JH, Chen SL. The effectiveness of community-based methodone maintenance treatment on the change of high-risk behavior among heroin addicts. Chinese J Drug Abuse Prev Treat 2010, 16(5):253-255.
43. Zhao YT, Xu HF, Fan LR. Evaluation for the community-based methadone maintenance treatment in Guangzhou City. J Trop Med 2009, 9(9):229-331.
44. van den Hoek JA, van Haastrecht HJ, Coutinho RA. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health 1989, 79(10):1355-1357. 10.2105/AJPH.79.10.1355, 1350173, 2782501.
45. Calsyn DA, Saxon AJ, Freeman G, Whittaker S. Ineffectiveness of AIDS education and HIV antibody testing in reducing high-risk behaviors among injection drug users. Am J Public Health 1992, 82(4):573-575. 10.2105/AJPH.82.4.573, 1694085, 1546776.
46. Farley TA, Cartter ML, Wassell JT, Hadler JL. Predictors of outcome in methadone programs: effect of HIV counseling and testing. AIDS 1992, 6(1):115-121. 10.1097/00002030-199201000-00016, 1543554.
47. Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, De Cock KM. The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals. Am J Public Health 2001, 91(7):1019-1024. 1446705, 11441723.
48. Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997. Am J Public Health 1999, 89(9):1397-1405. 10.2105/AJPH.89.9.1397, 1508752, 10474559.
49. Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in baltimore, Maryland. Clin Infect Dis 2002, 35(7):783-788. 10.1086/342063, 12228813.
50. Vidal-Trécan G, Coste J, Varescon-Pousson I, Christoforov B, Boissonnas A. HCV status knowledge and risk behaviours amongst intravenous drug users. Eur J Epidemiol 2000, 16(5):439-445. 10.1023/A:1007622831518, 10997831.
51. Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, Hudson S, Garfein RS. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep 2006, 121(6):710-719. 1781913, 17278406.
52. Wu J, Huang J, Xu D, Lu C, Deng X, Zhou X. Infection status and risk factors of HIV, HBV, HCV, and syphilis among drug users in Guangdong, China-a cross-sectional study. BMC Public Health 2010, 1(10):657.
53. Ramli M, Zafri AB, Junid MR, Hatta S. Associated risk factors to non-compliance to methadone maintenance therapy. Med J Malaysia 2012, 67(6):560-564.
54. Zhao L, Holzemer WL, Tulsky JP, Johnson MO, Dawson RC. Effect of methadone dose on maintenance treatment and health consequences among heroin addicts in South China. Subst Use Misuse 2013, in press.
55. Latkin CA, Davey-Rothwell MA, Knowlton AR, Alexander KA, Williams CT, Boodram B. Social network approaches to recruitment, HIV prevention, medical care, and medication adherence. J Acquir Immune Defic Syndr 2013, 63(Suppl 1):54-58.
56. Pang L, Hao Y, Mi G, Wang C, Luo W, Rou K, Li J, Wu ZY. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS 2007, 21(Suppl 8):103-107. 10.1097/01.aids.0000304704.71917.64, 17148975.
57. Shi J, Zhao LY, Epstein DH, Zhao C, Shuai Y, Yan B, Jin J, Lu L. The effect of methadone maintenance on illicit opioid use, human immunodeficiency virus and hepatitis C virus infection, health status, employment, and criminal activity among heroin abusers during 6 months of treatment in china. J Addict Med 2007, 1(4):186-190. 10.1097/ADM.0b013e318156cc19, 21768956.